Tech Company Financing Transactions
Sherlock Biosciences Funding Round
Sherlock Biosciences, based in Cambridge, scored investment capital from Bill & Melinda Gates Foundation.
Transaction Overview
Company Name
Announced On
11/29/2022
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Funding from the foundation has supported platform advancements that are addressing critical gaps in current solutions including the need for portable, disposable, low-cost diagnostic tests that can be deployed in low-resource environments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Sherlock Biosciences is disrupting diagnostics. Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide. Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Feng Zhang
Chief Executive Officer
Rahul Dhanda
Chief Technical Officer
William Blake
Co-Founder
Omar Abudayyeh
Co-Founder
James Collins
Co-Founder
Todd Golub
Co-Founder
Jonathan Gootenberg
Co-Founder
Deborah Hung
Co-Founder
Pardis Sabeti
Co-Founder
David Walt
Browse more venture capital transactions:
Prev: 11/29/2022: MeliBio venture capital transaction
Next: 11/29/2022: Propagate venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs